FDA Adverse Event Injury Summary report: N

M2A-MAGNUM RECAP CUP 54ODX48ID

MDR report key: 7792810 · Received August 17, 2018

Report

Report Number
3002806535-2018-00957
Event Type
Injury
Date Received
August 17, 2018
Date of Event
March 1, 2007
Report Date
May 3, 2019
Manufacturer
BIOMET UK LTD.
Product Code
KWA
Removal / Correction Number
N/A
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
DA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

(B)(4). THIS FOLLOW-UP REPORT IS BEING SUBMITTED TO RELAY ADDITIONAL INFORMATION. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Description of Event or Problem · 0

THE PATIENT UNDERWENT A HIP REVISION DUE TO EARLY INFECTION.

Additional Manufacturer Narrative · 1

(B)(4). CONCOMITANT MEDICAL PRODUCT - BI-METRIC POROUS FMRL 10X130MM , ITEM 162252, LOT 1233569, THERAPY DATE - (B)(6) 2007; M2A-MAGNUM 42-50 TPR INSRT STD , ITEM 139256, LOT 1123394, THERAPY DATE - (B)(6) 2007; MEDICAL PRODUCT - M2A-MAGNUM MOD HD SZ 48MM , ITEM 157448, LOT 1212280, THERAPY DATE - (B)(6) 2007. (B)(6). REPORTED EVENT WAS UNABLE TO BE CONFIRMED DUE TO LIMITED INFORMATION RECEIVED FROM CUSTOMER. DEVICE HISTORY RECORD (DHR) WAS REVIEWED AND NO DISCREPANCIES WERE FOUND. ROOT CAUSE WAS UNABLE TO BE DETERMINED AS THE NECESSARY INFORMATION TO ADEQUATELY INVESTIGATE THE REPORTED EVENT WAS NOT PROVIDED. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS: 3002806535-2018- 00954,3002806535-2018-00955 AND 3002806535-2018-00956.

Description of Event or Problem · 1

INFORMATION RECEIVED UPON REVIEW OF JOURNAL ARTICLE ENTITLED "A RANDOMIZED SEVEN-YEAR STUDY ON PERFORMANCE OF THE STEMMED METAL M2A-MAGNUM AND CERAMIC C2A-TAPER, AND THE RESURFACING RECAP HIP IMPLANTS" BY SØREN RIBEL-MADSEN ET AL (2017). A B S T R A C T: BACKGROUND: THE LARGE-DIAMETER METAL-ON-METAL HIP PROSTHESES WERE EXPECTED TO HAVE LOW WEAR AND REDUCED DISLOCATION RATE COMPARED TO THE TRADITIONAL METAL-ON-POLYETHYLENE IMPLANTS. WE COMPARE 2 SUCH PROSTHESES, THE RECAP RESURFACING IMPLANT AND THE M2A-MAGNUM STEMMED IMPLANT, WITH THE C2A CERAMIC-ON-CERAMIC STEMMED IMPLANT AS TO CLINICAL PERFORMANCE, SERUM CONCENTRATIONS OF PROSTHESIS METALS, AND THE DURABILITY OF THE IMPLANTS IN A RANDOMIZED, CONTROLLED CLINICAL TRIAL AT 7 YEARS OF FOLLOW-UP. METHODS: ALL INCLUDED PATIENTS HAD OSTEOARTHRITIS. PREOPERATIVELY, THE SIZE OF THE IMPLANTS WAS ESTIMATED FROM A MAGNETIC RESONANCE IMAGING (MRI) SCAN. FOLLOW-UP DATA INCLUDED SERUM COBALT AND CHROMIUM CONCENTRATIONS, OXFORD AND HARRIS HIP SCORES, LEG PRESS AND ABDUCTION FORCE, 6-MINUTE WALK DISTANCE, WOMAC AND SF-36 SELF-ASSESSMENT SCORES, AND FROM THE 7TH POSTOPERATIVE YEAR ALSO ULTRASONOGRAPHY (US) EXAMINATION OF THE SOFT TISSUE ADJACENT TO THE IMPLANT AS WELL AS MRI WITH METAL ARTIFACT REDUCTION SEQUENCE (MARS-MRI) WHEN INDICATED. RESULTS: ONE HUNDRED FIFTY-TWO HIPS IN 146 PATIENTS WERE INCLUDED. THE SERUM COBALT AND CHROMIUM CONCENTRATIONS WERE SIGNIFICANTLY HIGHER FOR THE 2 METAL-ON-METAL PROSTHESES THAN FOR THE CERAMIC-ONCERAMIC, WITH THE M2A-MAGNUM AS THE HIGHEST. NO SIGNIFICANT DIFFERENCE WAS FOUND BETWEEN THE GROUPS CONCERNING PHYSICAL PERFORMANCE MEASUREMENTS AND SCORES AS WELL AS DISLOCATIONS AND PROSTHESIS SURVIVAL. FIVE REVISIONS WERE DONE AND CONCERNED ALL GROUPS, FOR REASONS OF PAIN, HIGH SERUM COBALT AND CHROMIUM CONCENTRATIONS, CYSTIC FLUID COLLECTION AROUND THE JOINT, AND INFECTION. METAL CONCENTRATIONS, US, AND MARS-MRI CONTRIBUTED TO THE DECISION MAKING REGARDING PROSTHESIS REVISION. CONCLUSION: METAL CONCENTRATIONS WERE SIGNIFICANTLY HIGHER FOR THE METAL-ON-METAL PROSTHESES THAN FOR THE CERAMIC-ON-CERAMIC. THE CLINICAL PERFORMANCE WAS GOOD IN ALL 3 PROSTHESIS GROUPS. METAL CONCENTRATIONS, US, AND MARS-MRI FINDINGS WERE OF USE TO IDENTIFY HIPS NEEDING REVISION. THIS COMPLAINT REPORTS A PATIENT UNDERWENT HIP REVISION DUE TO EARLY INFECTION (PAGE 6, "DIAGNOSTICS OF IMPLANT FAILURES, AND REVISIONS DONE")

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
633536 M2A-MAGNUM RECAP CUP 54ODX48ID KWA BIOMET UK LTD. 1213463

Patients

Seq Age Sex Outcome Treatment
1 76 YR Hospitalization| R